The oncogenetic landscape and clinical impact of BCL11B alterations in adult and pediatric T-cell acute lymphoblastic leukemia

Haematologica. 2023 Nov 1;108(11):3165-3169. doi: 10.3324/haematol.2022.282605.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Child
  • Humans
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / genetics
  • Repressor Proteins
  • T-Lymphocytes
  • Transcription Factors
  • Tumor Suppressor Proteins

Substances

  • Transcription Factors
  • Tumor Suppressor Proteins
  • BCL11B protein, human
  • Repressor Proteins

Grants and funding

Funding: The GRAALL was supported by grants P0200701 and P030425/AOM03081 from the Programme Hospitalier de Recherche Clinique, Ministère de l’Emploi et de la Solidarité, France and the Swiss Federal Government in Switzerland. Samples were collected and processed by the AP-HP “Direction de Recherche Clinique” Tumor Bank at Necker-Enfants Malades. MED was supported by “CARPEM”. MS was supported by « Action Leucémie » and « Soutien pour la formation à la recherche translationnelle en cancérologie dans le cadre du Plan cancer 2009-2013 ». LC was supported by “Fondation pour la Recherche Médicale”. GA was supported by “Fondation de France”. This work was supported by grants to Necker laboratory from the “Association Laurette Fugain”, Institut National du Cancer PRT-K 18-071 and PLBIO2021-097-PL